Deerfield, IL, United States of America

Paula N Friedman



Average Co-Inventor Count = 9.9

ph-index = 9

Forward Citations = 204(Granted Patents)


Location History:

  • Buffalo Grove, IL (US) (2005)
  • Deerfield, IL (US) (1999 - 2009)

Company Filing History:


Years Active: 1999-2009

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: **Paula N. Friedman: Innovator in Breast and Prostate Disease Detection**

Introduction

Paula N. Friedman, based in Deerfield, IL, is a prominent inventor with an impressive portfolio of 21 patents. Her groundbreaking work in the field of medical diagnostics has significantly contributed to the detection and treatment of breast and prostate diseases, including cancer.

Latest Patents

Friedman's latest innovations include two pivotal patents focused on detecting diseases of the breast and prostate. The first patent introduces a set of contiguous and partially overlapping RNA sequences and polypeptides, designated as BS106, which are transcribed from breast tissue. This invention aims to facilitate the detecting, diagnosing, and treating of various conditions, particularly breast cancer. It also includes antibodies that specifically bind to the BS106-encoded polypeptide, presenting potential pathways for therapeutic intervention in breast diseases.

The second patent is centered on the detection of prostate diseases, utilizing RNA sequences and polypeptides designated as PS190, derived from prostate tissue. Similar to her work on breast cancer, this patent provides methods for diagnosis, prevention, and treatment of prostate conditions, with the ability to significantly impact patient prognosis and management.

Career Highlights

Paula N. Friedman has made notable strides in her career through her affiliation with Abbott Laboratories Corporation. Her innovative contributions have helped advance the field of medical diagnostics, particularly in relation to diseases that affect millions of individuals globally.

Collaborations

Throughout her career, Friedman has collaborated with esteemed colleagues in her field, including Maurice Cohen and Michael R. Klass. These collaborations have been instrumental in the development and refinement of her patented technologies, further enhancing their applicability and efficacy in real-world medical settings.

Conclusion

In summary, Paula N. Friedman stands as a significant figure in medical innovation, with her patents paving the way for improved diagnostic methods for breast and prostate diseases. Her work not only represents a substantial advancement in the field but also reflects a commitment to enhancing patient care and treatment outcomes through innovative science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…